{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:01:55Z","timestamp":1758052915895,"version":"3.44.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clinbiochem.2023.110615","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T17:19:43Z","timestamp":1690564783000},"page":"110615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-M\u00fcllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer"],"prefix":"10.1016","volume":"119","author":[{"given":"Xiuzhu","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10177","key":"10.1016\/j.clinbiochem.2023.110615_b0005","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2023.110615_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110615_b0015","first-page":"25","article-title":"Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study","volume":"31","author":"Guleria","year":"2020","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110615_b0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2017.11.024","article-title":"Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study","volume":"148","author":"Guleria","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2023.110615_b0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/bmm-2021-1014","article-title":"BRAK and APRIL as novel biomarkers for ovarian tumors","volume":"16","author":"Kim","year":"2022","journal-title":"Biomark. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110615_b0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.path.2021.05.006","article-title":"Molecular Pathology of Ovarian Epithelial Neoplasms","volume":"14","author":"Ordulu","year":"2021","journal-title":"Surgical Pathology Clinics"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110615_b0035","first-page":"1163","article-title":"Serological and immunohistochemical biomarkers for discrimination between benign and malignant ovarian tumors","volume":"60","author":"Dijm\u0103rescu","year":"2019","journal-title":"Rom. J. Morphol. Embryol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110615_b0040","doi-asserted-by":"crossref","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110615_b0045","first-page":"738","article-title":"CA125 measured during menstruation can be misleading. [case report]","volume":"111","author":"Crosby","year":"2018","journal-title":"Ir. Med. J."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110615_b0050","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/cancers12123730","article-title":"CA125 and Ovarian Cancer: A Comprehensive Review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"04","key":"10.1016\/j.clinbiochem.2023.110615_b0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0040-1722547","article-title":"Benign Ovarian Cysts with Raised CA-125 Levels: Do We Need to Evaluate the Fallopian Tubes?","volume":"12","author":"Sharma","year":"2020","journal-title":"J Lab Physicians"},{"key":"10.1016\/j.clinbiochem.2023.110615_b0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejogrb.2014.12.008","article-title":"Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma","volume":"185","author":"Kil","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110615_b0065","first-page":"688","article-title":"Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis","volume":"25","author":"Feng","year":"2020","journal-title":"J BUON. Mar-Apr"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110615_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10238-004-0047-y","article-title":"Production of CA125 by human lung cancer cell lines","volume":"4","author":"Homma","year":"2004","journal-title":"Clin. Exp. Med."},{"issue":"7","key":"10.1016\/j.clinbiochem.2023.110615_b0075","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00432-011-0977-1","article-title":"Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer","volume":"137","author":"Mury","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110615_b0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2012.03.011","article-title":"Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women","volume":"125","author":"Hallamaa","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110615_b0085","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00404-020-05527-0","article-title":"The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125","volume":"301","author":"Li","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110615_b0090","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1007\/s13277-016-5335-0","article-title":"Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer","volume":"37","author":"Shen","year":"2016","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110615_b0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J Ovarian Res."},{"issue":"440","key":"10.1016\/j.clinbiochem.2023.110615_b0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2014.11.015","article-title":"ROMA, an algorithm for ovarian cancer","volume":"2","author":"Chudecka-G\u0142az","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110615_b0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2016.03.039","article-title":"Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice","volume":"151","author":"Bergstrom","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110615_b0110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2019.12.025","article-title":"A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer","volume":"156","author":"Salminen","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2023.110615_b0115","doi-asserted-by":"crossref","first-page":"e0201314","DOI":"10.1371\/journal.pone.0201314","article-title":"Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma","volume":"13","author":"Eavarone","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110615_b0120","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2023.110615_b0125","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fendo.2020.00641","article-title":"Role of Anti-M\u00fcllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome","volume":"11","author":"Dewailly","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110615_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13224-020-01362-0","article-title":"AMH and Its Clinical Implications","volume":"70","author":"Shrikhande","year":"2020","journal-title":"J. Obstet. Gynaecol. India"},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110615_b0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-121-2-199407150-00009","article-title":"Screening for ovarian cancer","volume":"121","author":"Carlson","year":"1994","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110615_b0140","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1186\/s12889-020-09267-3","article-title":"Space-time analysis of ovarian cancer mortality rates by age groups in spanish provinces (1989\u20132015)","volume":"20","author":"Trandafir","year":"2020","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110615_b0145","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3109\/09513590.2011.569788","article-title":"Benefits and risks of ovarian function and reproduction for cancer development and prevention","volume":"27","author":"Schindler","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2023.110615_b0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humpath.2022.04.008","article-title":"Precursors in the ovarian stroma: another pathway to explain the origin of ovarian serous neoplasms","volume":"127","author":"Silva","year":"2022","journal-title":"Hum Pathol. Hum Pathol."},{"key":"10.1016\/j.clinbiochem.2023.110615_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/517239","article-title":"Serum anti-m\u00fcllerian hormone levels in patients with epithelial ovarian cancer","volume":"2013","author":"Walentowicz","year":"2013","journal-title":"Int J Endocrinol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110615_b0160","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1055-9965.EPI-19-0675","article-title":"Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank","volume":"29","author":"Irvin","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110615_b0165","first-page":"14141","article-title":"Early diagonosis of ovarian cancer: serum HE4, CA125 and ROMA model","volume":"13","author":"Wang","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110615_b0170","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.21037\/gs-21-666","article-title":"Modified HE4, CA125, and ROMA cut-off values and predicted probability of ovarian tumor in Chinese patients","volume":"10","author":"Zhao","year":"2021","journal-title":"Gland Surg."},{"issue":"9","key":"10.1016\/j.clinbiochem.2023.110615_b0175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.21037\/atm-20-8053","article-title":"CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110615_b0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.06.040","article-title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","volume":"99","author":"Rosen","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110615_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22624","article-title":"Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer","volume":"33","author":"Kim","year":"2019","journal-title":"J. Clin. Lab Anal."},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110615_b0190","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.clinbiochem.2023.110615_b0195","doi-asserted-by":"crossref","first-page":"e1003295","DOI":"10.1371\/journal.pmed.1003295","article-title":"The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study","volume":"17","author":"Funston","year":"2020","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110615_b0200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000442288","article-title":"CA125 and HE4: Measurement Tools for Ovarian Cancer","volume":"81","author":"Zhao","year":"2016","journal-title":"Gynecol. Obstet. Invest."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110615_b0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.currproblcancer.2018.06.001","article-title":"Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis","volume":"43","author":"Zhang","year":"2019","journal-title":"Curr. Probl. Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110615_b0210","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3892\/mmr.2015.4062","article-title":"Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125","volume":"12","author":"Mckinnon","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"19","key":"10.1016\/j.clinbiochem.2023.110615_b0215","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.3390\/cancers13194764","article-title":"HE4 as a Biomarker for Endometrial Cancer","volume":"13","author":"Behrouzi","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110615_b0220","doi-asserted-by":"crossref","first-page":"284","DOI":"10.30699\/ijp.2021.135323.2482","article-title":"HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression","volume":"16","author":"Mirmohseni Namini","year":"2021","journal-title":"Iran J. Pathol."},{"issue":"15","key":"10.1016\/j.clinbiochem.2023.110615_b0225","doi-asserted-by":"crossref","first-page":"e021069","DOI":"10.1161\/JAHA.120.021069","article-title":"HE4 Predicts Progressive Fibrosis and Cardiovascular Events in Patients With Dilated Cardiomyopathy","volume":"10","author":"Yamamoto","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.clinbiochem.2023.110615_b0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cca.2019.10.002","article-title":"Diagnostic performance of HE4 and ROMA among Chinese women","volume":"500","author":"Shen","year":"2020","journal-title":"Clin. Chim. Acta"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:59:21Z","timestamp":1757865561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912023001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":46,"alternative-id":["S0009912023001431"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110615","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-M\u00fcllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110615"}}